{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T22:16:11Z","timestamp":1792880171145,"version":"4.5.0"},"reference-count":34,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2014,8,1]],"date-time":"2014-08-01T00:00:00Z","timestamp":1406851200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,6,27]],"date-time":"2014-06-27T00:00:00Z","timestamp":1403827200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/3.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2014,8]]},"DOI":"10.1016\/j.intimp.2014.06.001","type":"journal-article","created":{"date-parts":[[2014,6,11]],"date-time":"2014-06-11T19:21:54Z","timestamp":1402514514000},"page":"468-473","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":64,"title":["Therapeutic efficacy of infused molecular hydrogen in saline on rheumatoid arthritis: A randomized, double-blind, placebo-controlled pilot study"],"prefix":"10.1016","volume":"21","author":[{"given":"Toru","family":"Ishibashi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bunpei","family":"Sato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinji","family":"Shibata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takaaki","family":"Sakai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuichi","family":"Hara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuji","family":"Naritomi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samon","family":"Koyanagi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Hara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetsuhiko","family":"Nagao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.intimp.2014.06.001_bb0005","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1056\/NEJMra1004965","article-title":"The pathogenesis of rheumatoid arthritis","volume":"365","author":"McInnes","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.intimp.2014.06.001_bb0010","first-page":"E427","article-title":"Painful rheumatoid arthritis","volume":"14","author":"Smith","year":"2011","journal-title":"Pain Physician"},{"key":"10.1016\/j.intimp.2014.06.001_bb0015","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1093\/intimm\/dxq030","article-title":"IL-6: from its discovery to clinical applications","volume":"22","author":"Kishimoto","year":"2010","journal-title":"Int Immunol"},{"key":"10.1016\/j.intimp.2014.06.001_bb0020","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S0092-8674(00)81109-5","article-title":"Rheumatoid arthritis","volume":"85","author":"Feldmann","year":"1996","journal-title":"Cell"},{"key":"10.1016\/j.intimp.2014.06.001_bb0025","doi-asserted-by":"crossref","first-page":"6375","DOI":"10.2174\/13816128113199990507","article-title":"Molecular hydrogen: new antioxidant and anti-inflammatory therapy for rheumatoid arthritis and related diseases","volume":"19","author":"Ishibashi","year":"2013","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.intimp.2014.06.001_bb0030","first-page":"7","article-title":"The role of free radicals in the pathogenesis of rheumatoid arthritis","volume":"45","author":"Hadjigogos","year":"2003","journal-title":"Panminerva Med"},{"key":"10.1016\/j.intimp.2014.06.001_bb0035","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1042\/BST0391226","article-title":"Measurement and meaning of markers of reactive species of oxygen, nitrogen and sulfur in healthy human subjects and patients with inflammatory joint disease","volume":"39","author":"Winyard","year":"2011","journal-title":"Biochem Soc Trans"},{"key":"10.1016\/j.intimp.2014.06.001_bb0040","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1089\/ars.2009.2607","article-title":"Aberrant reactive oxygen and nitrogen species generation in rheumatoid arthritis (RA): causes and consequences for immune function, cell survival, and therapeutic intervention","volume":"12","author":"Phillips","year":"2010","journal-title":"Antioxid Redox Signal"},{"key":"10.1016\/j.intimp.2014.06.001_bb0045","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/S0764-4469(01)01350-6","article-title":"Anti-inflammatory properties of molecular hydrogen: investigation on parasite-induced liver inflammation","volume":"324","author":"Gharib","year":"2001","journal-title":"C R Acad Sci III"},{"key":"10.1016\/j.intimp.2014.06.001_bb0050","doi-asserted-by":"crossref","first-page":"353152","DOI":"10.1155\/2012\/353152","article-title":"Molecular hydrogen as an emerging therapeutic medical gas for neurodegenerative and other diseases","volume":"2012","author":"Ohno","year":"2012","journal-title":"Oxidative Med Cell Longev"},{"key":"10.1016\/j.intimp.2014.06.001_bb0055","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1152\/jappl.1994.76.3.1113","article-title":"Psychophysiological reactions in humans during an open sea dive to 500m with a hydrogen\u2013helium\u2013oxygen mixture","volume":"76","author":"Abraini","year":"1994","journal-title":"J Appl Physiol"},{"key":"10.1016\/j.intimp.2014.06.001_bb0060","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/s004210050050","article-title":"Changes in maximal performance of inspiratory and skeletal muscles during and after the 7.1-MPa Hydra 10 record human dive","volume":"81","author":"Fontanari","year":"2000","journal-title":"Eur J Appl Physiol"},{"key":"10.1016\/j.intimp.2014.06.001_bb0065","first-page":"107","article-title":"The prevention of decompression sickness and nitrogen narcosis by the use of hydrogen as a substitute for nitrogen, the Arne Zetterstr\u00f4m method for deep-sea diving","volume":"103","author":"Bjurstedt","year":"1948","journal-title":"Mil Surg"},{"key":"10.1016\/j.intimp.2014.06.001_bb0070","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1038\/nm1577","article-title":"Hydrogen acts as a therapeutic antioxidant by selectively reducing cytotoxic oxygen radicals","volume":"13","author":"Ohsawa","year":"2007","journal-title":"Nat Med"},{"key":"10.1016\/j.intimp.2014.06.001_bb0075","doi-asserted-by":"crossref","first-page":"2241","DOI":"10.2174\/138161211797052664","article-title":"Recent progress toward hydrogen medicine: potential of molecular hydrogen for preventive and therapeutic applications","volume":"17","author":"Ohta","year":"2011","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.intimp.2014.06.001_bb0080","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/2045-9912-2-27","article-title":"Consumption of water containing a high concentration of molecular hydrogen reduces oxidative stress and disease activity in patients with rheumatoid arthritis: an open-label pilot study","volume":"2","author":"Ishibashi","year":"2012","journal-title":"Med Gas Res"},{"key":"10.1016\/j.intimp.2014.06.001_bb0085","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/2045-9912-3-13","article-title":"Safety of intravenous administration of hydrogen-enriched fluid in patients with acute cerebral ischemia: initial clinical studies","volume":"3","author":"Nagatani","year":"2013","journal-title":"Med Gas Res"},{"key":"10.1016\/j.intimp.2014.06.001_bb0090","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/2045-9912-1-12","article-title":"Improved brain MRI indices in the acute brain stem infarct sites treated with hydroxyl radical scavengers, Edaravone and hydrogen, as compared to Edaravone alone. A non-controlled study","volume":"1","author":"Ono","year":"2011","journal-title":"Med Gas Res"},{"key":"10.1016\/j.intimp.2014.06.001_bb0095","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/2045-9912-2-1","article-title":"A convenient method for determining the concentration of hydrogen in water: use of methylene blue with colloidal platinum","volume":"2","author":"Seo","year":"2012","journal-title":"Med Gas Res"},{"key":"10.1016\/j.intimp.2014.06.001_bb0100","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1002\/art.1780380107","article-title":"Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis","volume":"38","author":"Prevoo","year":"1995","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.intimp.2014.06.001_bb0105","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1136\/ard.2010.138461","article-title":"2010 rheumatoid arthritis classification criteria: an American College of Rheumatology\/European League Against Rheumatism collaborative initiative","volume":"69","author":"Aletaha","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.intimp.2014.06.001_bb0110","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/S0140-6736(08)60454-7","article-title":"Efficacy and safety of tocilizumab in patients with systemic-onset juvenile idiopathic arthritis: a randomised, double-blind, placebo-controlled, withdrawal phase III trial","volume":"371","author":"Yokota","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.intimp.2014.06.001_bb0115","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1016\/j.ijsu.2013.10.007","article-title":"Heme oxygenase-1 mediates the anti-inflammatory effect of molecular hydrogen in LPS-stimulated RAW 264.7 macrophages","volume":"11","author":"Chen","year":"2013","journal-title":"Int J Surg"},{"key":"10.1016\/j.intimp.2014.06.001_bb0120","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1007\/s10067-013-2309-0","article-title":"Reduction of plasma IL-6 but not TNF-\u03b1 by methotrexate in patients with early rheumatoid arthritis: a potential biomarker for radiographic progression","volume":"32","author":"Nishina","year":"2013","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.intimp.2014.06.001_bb0125","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1038\/ncprheum0340","article-title":"Strategies to control disease in rheumatoid arthritis with tumor necrosis factor antagonists\u2014an opportunity to improve outcomes","volume":"2","author":"Keystone","year":"2006","journal-title":"Nat Clin Pract Rheumatol"},{"key":"10.1016\/j.intimp.2014.06.001_bb0130","doi-asserted-by":"crossref","first-page":"189","DOI":"10.5114\/aoms.2011.22067","article-title":"Role of anti-citrullinated protein antibodies in diagnosis and prognosis of rheumatoid arthritis","volume":"7","author":"Puszczewicz","year":"2011","journal-title":"Arch Med Sci"},{"key":"10.1016\/j.intimp.2014.06.001_bb0135","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1093\/rheumatology\/ker010","article-title":"The value of rheumatoid factor and anti-citrullinated protein antibodies as predictors of response to infliximab in rheumatoid arthritis: an exploratory study","volume":"50","author":"Klaasen","year":"2011","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.intimp.2014.06.001_bb0140","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/2045-9912-2-14","article-title":"Hydrogen (H2) treatment for acute erythymatous skin diseases. A report of 4 patients with safety data and a non-controlled feasibility study with H2 concentration measurement on two volunteers","volume":"2","author":"Ono","year":"2012","journal-title":"Med Gas Res"},{"key":"10.1016\/j.intimp.2014.06.001_bb0145","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1136\/ard.47.1.84-b","article-title":"Did Galen describe rheumatoid arthritis?","volume":"47","author":"Dieppe","year":"1988","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.intimp.2014.06.001_bb0150","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1046\/j.1440-1711.2003.01184.x","article-title":"Past, present and future drug treatment for rheumatoid arthritis and systemic lupus erythematosus","volume":"81","author":"Mottram","year":"2003","journal-title":"Immunol Cell Biol"},{"key":"10.1016\/j.intimp.2014.06.001_bb0155","doi-asserted-by":"crossref","first-page":"33","DOI":"10.3109\/03009748309102001","article-title":"Prognosis of inflammatory joint diseases. A three-year follow-up study","volume":"12","author":"Nissil\u00e4","year":"1983","journal-title":"Scand J Rheumatol"},{"issue":"Suppl. 12","key":"10.1016\/j.intimp.2014.06.001_bb0160","first-page":"3","article-title":"Historical perspective on the use of methotrexate for the treatment of rheumatoid arthritis","volume":"12","author":"Ward","year":"1985","journal-title":"J Rheumatol Suppl"},{"key":"10.1016\/j.intimp.2014.06.001_bb0165","doi-asserted-by":"crossref","first-page":"228","DOI":"10.3109\/s10165-008-0056-x","article-title":"Treatment of rheumatoid arthritis: a global perspective on the use of antirheumatic drugs","volume":"18","author":"Sokka","year":"2008","journal-title":"Mod Rheumatol"},{"key":"10.1016\/j.intimp.2014.06.001_bb0170","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1002\/art.1780361206","article-title":"Treatment of rheumatoid arthritis with chimeric monoclonal antibodies to tumor necrosis factor alpha","volume":"36","author":"Elliott","year":"1993","journal-title":"Arthritis Rheum"}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576914002124?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576914002124?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,11]],"date-time":"2019-08-11T12:52:38Z","timestamp":1565527958000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576914002124"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,8]]},"references-count":34,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,8]]}},"alternative-id":["S1567576914002124"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2014.06.001","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2014,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Therapeutic efficacy of infused molecular hydrogen in saline on rheumatoid arthritis: A randomized, double-blind, placebo-controlled pilot study","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2014.06.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}